Shares of McKesson Corp. MCK rallied 1.86% to $695.17 Tuesday, on what proved to be an all-around great trading session for ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other best value dividend stocks. Dividends, though sometimes underappreciated, have ...

IRVING, Texas, April 02, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks on Jim Cramer’s list to buy right now. On Monday, April 14th, Jim Cramer opened ...

Irving, Texas-based McKesson Corporation (MCK) is a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and healthcare technology solutions.

In a report released today, Daniel Grosslight from Citi maintained a Buy rating on McKesson (MCK – Research Report), with a price target of $800.00. Discover outperforming stocks and invest ...

$40,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to the pharmaceutical ...

Quad-C Management has sold its stake in Prism Vision, a New Providence, New Jersey-based provider of general ophthalmology and retina management services, to McKesson Corporation. No financial ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks that Jim Cramer discussed. On Thursday, Jim Cramer, host of Mad Money, described ...